* Alignment Healthcare Inc ALHC.OQ ALHC.O is expected
to show
a rise in quarterly revenue when it reports results on May 2
for the period ending January 1 0001
* The Orange California-based company is expected to report
a
36.1% increase in revenue to $597.48 million from $439.16
million a year ago, according to the mean estimate from 10
analysts, based on LSEG data.The company's guidance on February
27 2024, for the period ended March 31, was for revenue between
$590.00 million and $600.00 million.
* LSEG's mean analyst estimate for Alignment Healthcare Inc
is
for a loss of 22 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Alignment
Healthcare Inc is $8.25, above its last closing price
of $5.08.
The company's guidance on February 27 2024 for the period ended
March 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between 590 million and -13 million (USD).
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jan. 1 0001 -0.22 -0.22 -0.25 Missed -12.5
Jun. 30 0001 -0.18 -0.18 -0.18 Met 1.4
Jan. 1 0001 -0.21 -0.22 -0.15 Beat 31.4
Jan. 1 0001 -0.25 -0.20 Beat 21.4
Dec. -0.30 -0.31 Missed -4.3
31 2022
Sep. 30 2022 -0.24 -0.25 -0.22 Beat 10.5
Jan. 1 0001 -0.26 -0.26 -0.06 Beat 76.7
Jan. 1 0001 -0.25 -0.25 -0.23 Beat 6.5
This summary was machine generated April 30 at 22:05 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)